BioCentury
ARTICLE | Clinical News

Peregrine preclinical data

October 20, 2014 7:00 AM UTC

In vitro data showed that bavituximab specifically binds to cells infected with Ebola virus and to purified Ebola virions. Data will be published in the Journal of Immunology Research. Bavituximab is ...